Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Cureus ; 14(11): e32082, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-2203372

ABSTRACT

Background Coronavirus disease 2019 (COVID-19) infection is associated with troponin elevation, which is associated with increased mortality. However, it is not clear if troponin elevation is independently linked to increased mortality in COVID-19 patients. Although there is considerable literature on risk factors for mortality in COVID-19-associated myocardial injury, the Global Registry of Acute Coronary Events (GRACE), Thrombolysis in Myocardial Infarction (TIMI), and Sequential Organ Failure Assessment (SOFA) scores have not been studied in COVID-19-related myocardial injury. This data is important in risk-stratifying COVID-19 myocardial injury patients. Methodology Of the 1,500 COVID-19 patients admitted to our hospitals, 217 patients who had troponin levels measured were included. Key variables were collected manually, and univariate and multivariate cox regression analysis was done to determine the predictors of mortality in COVID-19-associated myocardial injury. The differences in clinical profiles and outcomes of COVID-19 patients with and without troponin elevation were compared. Results Mortality was 26.5% in the normal troponin group and 54.6% in the elevated troponin group. Patients with elevated troponins had increased frequency of hypotension (p = 0.01), oxygen support (p < 0.01), low absolute lymphocyte (p < 0.01), elevated blood urea nitrogen (p < 0.01), higher C-reactive protein (p < 0.01), higher D-dimer (p < 0.01), higher lactic acid (p < 0.01), and higher Quick SOFA (qSOFA), SOFA, TIMI, and GRACE (all scores p < 0.01). On univariate cox regression, troponin elevation (hazard ratio (HR) = 1.85, 95% confidence interval (CI) = 1.18-2.88, p < 0.01), TIMI score >3 (HRv = 1.79, 95% CI = 1.11-2.75, p = 0.01), and GRACE score >140 (HR = 2.27, 95% CI = 1.45-3.55, p < 0.01) were highly associated with mortality, whereas cardiovascular disease (HR = 1.40, 95% CI = 0.89-2.21, p = 0.129) and cardiovascular risk factors (HR = 1.15, 95% CI = 0.73-1.81, p = 0.52) were not. After adjusting for age, use of a non-rebreather or high-flow nasal cannula, hemoglobin <8.5 g/dL, suspected or confirmed source of infection, and qSOFA and SOFA scores (HR = 1.18, 95% CI = 1.07-1.29, p < 0.01) were independently associated with mortality, whereas troponin (HR = 1.08, 95% CI = 0.63-1.85, p = 0.76), TIMI score (HR = 1.02, 95% CI = 0.99-1.06, p = 0.12) and GRACE scores (HR = 1.01, 95% CI = 0.99-1.02, p = 0.10) were not associated with mortality. Conclusions Our study shows that troponin, GRACE score, and TIMI score are not independent predictors of mortality in COVID-19 myocardial injury. This may be because troponin elevation in COVID-19 patients may be related to demand ischemia rather than acute coronary syndrome-related. This was shown by the association of troponin with a higher degree of systemic inflammation and end-organ dysfunction. Therefore, we recommend SOFA scores in risk-stratifying COVID-19 patients with myocardial injury.

2.
Hygiene and Environmental Health Advances ; : 100025, 2022.
Article in English | ScienceDirect | ID: covidwho-2031294

ABSTRACT

The deadly transmission of the coronavirus forced all countries to implement lockdowns to restrict the transmission of this highly infectious disease. As a result of these lockdowns and restrictions, many urban centers have seen a positive impact on air quality with a significant reduction in air pollution. Therefore, in this study, the impact of COVID-19 lockdown vis-a-vis meteorological parameters on the ambient air quality of Srinagar city was examined. In this regard, we have evaluated the temporal variation of six different key air pollutants (PM10, PM2.5, SO2, NO2, O3, and NH3) along with meteorological parameters (relative humidity, rainfall, temperature, wind speed, and wind direction). The duration of the study was divided into three periods: Before Lockdown(BLD), Lockdown (LD), and Partial Lockdown(PLD). Daily average data for all the parameters was accessed from one of the real-time continuous monitoring stations of the central pollution control board (CPCB) at Rajbagh Srinagar. Some air pollutants have decreased, according to the results, while others have increased. The air quality index (AQI) decreases overall by 6.15 percent compared to before lockdown, and it never exceeds the "moderate" category. The AQI was in the following order for both lockdown and pre-lockdown periods: satisfactory > moderate > good. However, for partial lockdown, it was moderate > satisfactory > good. It was observed that the maximum decrease was seen in the concentration of NO2, NH3 with 75.11% and 69.18%. A modest decrease was observed in PM10 at 3.8%. While SO2 and O3 had an upward trend of 85.82% and 48.74%, The NO2 to SO2 ratio reveals that the emissions of NO2 have substantially decreased due to the complete restriction of transport systems. From principal component analysis for all three study periods, PM10 and PM2.5 were combined into a single component, inferring their shared behavior and source of origin. SO2 and O3 demonstrated identical behavior during the lockdown and partial lockdown periods of study. According to the findings of the study, it is beneficial for the government, environmentalists, and policymakers to impose rigorous lockdown measures, particularly during extreme air pollution events, in order to reduce the damage caused by automotive and industrial emissions.

3.
Anal Chem ; 93(22): 7797-7807, 2021 06 08.
Article in English | MEDLINE | ID: covidwho-1241778

ABSTRACT

The COVID-19 pandemic has underscored the shortcomings in the deployment of state-of-the-art diagnostics platforms. Although several polymerase chain reaction (PCR)-based techniques have been rapidly developed to meet the growing testing needs, such techniques often need samples collected through a swab, the use of RNA extraction kits, and expensive thermocyclers in order to successfully perform the test. Isothermal amplification-based approaches have also been recently demonstrated for rapid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection by minimizing sample preparation while also reducing the instrumentation and reaction complexity. In addition, there are limited reports of saliva as the sample source, and some of these indicate inferior sensitivity when comparing reverse transcription loop-mediated isothermal amplification (RT-LAMP) with PCR-based techniques. In this paper, we demonstrate an improved sensitivity assay from saliva using a two-step RT-LAMP assay, where a short 10 min RT step is performed with only B3 and backward inner primers before the final reaction. We show that while the one-step RT-LAMP demonstrates satisfactory results, the optimized two-step approach allows detection of only few molecules per reaction and performs significantly better than the one-step RT-LAMP and conventional two-step RT-LAMP approaches with all primers included in the RT step. We show control measurements with RT-PCR, and importantly, we demonstrate RNA extraction-free RT-LAMP-based assays for detection of SARS-CoV-2 from viral transport media and saliva clinical samples.


Subject(s)
COVID-19 , Reverse Transcription , COVID-19 Testing , Humans , Molecular Diagnostic Techniques , Nucleic Acid Amplification Techniques , Pandemics , RNA, Viral/genetics , SARS-CoV-2 , Saliva , Sensitivity and Specificity
4.
Journal of the American College of Cardiology ; 77(18, Supplement 1):3063, 2021.
Article in English | ScienceDirect | ID: covidwho-1213715
5.
Cardiorenal Med ; 10(6): 462-469, 2020.
Article in English | MEDLINE | ID: covidwho-889976

ABSTRACT

INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a pandemic that has affected >188 countries, involved >24 million people, and caused >840,000 deaths. COVID-19, in its severe form, presents as acute respiratory distress syndrome (ARDS), shock, and multiorgan failure. Thrombotic microangiopathy of the lungs and kidneys has been observed in these patients. Elevated D-dimer levels have been observed in people with serious COVID-19 illness, and this could be helpful in guiding treatment with anticoagulation in these patients. OBJECTIVE: To analyze the role of anticoagulation as a treatment modality for COVID-19. METHODS: We present the unique case of a COVID-19 patient who developed sepsis, ARDS, acute kidney injury, and deep-vein thrombosis (DVT), who was deteriorating clinically. She was treated with anticoagulation. RESULTS: There was rapid recovery after treatment with systemic anticoagulation. CONCLUSIONS: Systemic anticoagulation could prove to be essential in the treatment of CO-VID-19. Further studies are required to assess its role in improving long-term morbidity and mortality in these patients.


Subject(s)
COVID-19/complications , SARS-CoV-2/genetics , Thromboembolism/etiology , Acute Kidney Injury/diagnosis , Acute Kidney Injury/etiology , Anticoagulants/therapeutic use , COVID-19/epidemiology , COVID-19/virology , Cytokine Release Syndrome/diagnosis , Cytokine Release Syndrome/etiology , Female , Fibrin Fibrinogen Degradation Products/analysis , Humans , Middle Aged , Respiratory Distress Syndrome/diagnosis , Respiratory Distress Syndrome/etiology , Sepsis/diagnosis , Sepsis/etiology , Thromboembolism/diagnosis , Thromboembolism/prevention & control , Thrombotic Microangiopathies/complications , Thrombotic Microangiopathies/prevention & control , Treatment Outcome , Venous Thrombosis/diagnosis , Venous Thrombosis/etiology
SELECTION OF CITATIONS
SEARCH DETAIL